Policy Change

A coalition of top GOP senators and state attorneys general is urging the FDA to pull mifepristone, escalating the fight over abortion to the federal level.

As global AI laws create a complex maze for businesses, a new startup launches an AI-native platform to automate compliance and stay ahead of the rules.

With new funding from BroadOak Capital Partners, Axol Bioscience is set to expand its revolutionary iPSC-based disease models in the US market.

Moving beyond hype, ArisGlobal's record growth and enterprise adoption of its NavaX AI show the pharmaceutical industry is now operationalizing AI at scale.

San Juan's airport is set to launch a $14M solar microgrid, promising major savings and crucial energy stability for the island's vital travel hub.

A new partnership between Clutch and Google Public Sector aims to reshape services for millions, navigating a complex landscape of innovation and ethics.

RAAPID’s award-winning Neuro-Symbolic AI brings transparency to risk adjustment, promising audit-ready accuracy and major ROI for value-based care.

As cannabis moves to Schedule III, a top consulting firm unveils expert witness and lab services to navigate a new landscape of regulation and litigation.

A new system for private-label diapers replaces vague eco-claims with machine-readable compliance data, promising a new era of transparency for retailers.

As extreme weather disrupts learning, a new research-backed guide helps schools protect student well-being and academic continuity.

A new 16-year deal with SES for irreplaceable UHF satellite capacity gives Australia a vital strategic edge in an increasingly contested Indo-Pacific.

With new federal guidelines backing whole foods, programs delivering 'prescription produce' are proving they can cut healthcare costs and fight chronic disease.

Facing fines and state-level sanctions, crypto firm Coinme appoints veteran fintech attorney Hazen Baron to navigate a treacherous legal and regulatory path.

The clean-energy firm is commercializing its tech, securing a 10-year fuel deal in Portugal and deploying rail turbines as it seeks greater market access.

A new poll shows Iowans are furious over rising medical bills. With bipartisan anger mounting, the issue could reshape the 2026 political landscape.

As the SF Zoo faces a financial crisis, a poll reveals overwhelming public support for a bold plan to replace it with a $350M conservation-focused EcoPark.

A major new partnership is racing to deploy predictive tech, from blood tests to eye scans, to prevent millions of stillbirths in years, not decades.

Moderna CEO Stephane Bancel joins CFS's board, signaling a major push to commercialize fusion energy. Can his vaccine scale-up success crack the code?

Palladyne AI launches its IQ 2.0 software, a low-code platform aiming to overhaul defense manufacturing in line with new government mandates.

Com Laude's acquisition of Markmonitor creates a $450M registrar giant, timed perfectly for a rare 'dotBrand' TLD land rush set for mid-2026.